Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-70 of 125 for Ovarian

Edit search filters
  1. Everolimus And Letrozole In Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, Or Primary Peritoneal Cavity Cancer

    Jacksonville, FL, Rochester, MN

  2. Gemcitabine Hydrochloride Alone Or With M6620 In Treating Patients With Recurrent Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Rochester, MN

  3. Veliparib And Topotecan Hydrochloride In Treating Patients With Solid Tumors, Relapsed Or Refractory Ovarian Cancer, Or Primary Peritoneal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study Of Pembrolizumab Alone Or Combined With CC-486 For Patients With Platinum-Resistant Ovarian, Fallopian Tube, Or Peritoneal Cancer

    Rochester, MN

  5. A Study For Women Who Have Platinum Resistant Ovarian Cancer To Evaluate EC145 Combined With Pegylated Liposomal Doxorubicin, Compared To Pegylated Liposomal Doxorubicin Alone

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate AVB-S6-500 With Paclitaxel Vs Paclitaxel In Patients With Platinum-resistant Recurrent Ovarian Cancer

    Rochester, MN

  7. A Study Of Niraparib Combined With Pembrolizumab (MK-3475) In Patients Who Have Triple-Negative Breast Cancer Or Ovarian Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Veliparib And Floxuridine In Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, Or Fallopian Tube Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study Of Niraparib Maintenance Treatment In Patients With Advanced Ovarian Cancer Following Response On Front-Line Platinum-Based Chemotherapy

    Jacksonville, FL

  10. Gemini Study To Evaluate The Integration Of Cancer Genetic Testing Into A Cancer Clinical Practice At Mayo Clinic At Arizona

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer